HOME >> MEDICINE >> NEWS
Landmark dialysis study findings could greatly simplify treatment of kidney disease with peritoneal dialysis

Montreal, Canada, June 28, 2001 - Data presented from the largest randomized controlled clinical trial ever completed in dialysis patients suggest that peritoneal dialysis (PD), a flexible home-based dialysis treatment for people with chronic kidney failure, might have far broader applicability than current practice patterns suggest. This study, led by researchers in Mexico and conducted under the auspices of the Mexican healthcare authorities , and supported by Baxter Healthcare Corporation and its Mexico affiliate, was presented this week at an invited scientific session at the IX Congress of the International Society for Peritoneal Dialysis (ISPD) in Montreal.

According to Peter G. Blake, M.D., associate professor of medicine at the University of Western Ontario, Canada, and member of the National Kidney Foundation Dialysis Outcomes Quality Initiative (DOQI) Peritoneal Dialysis Adequacy Workgroup, "This is a pivotal study for the nephrology community worldwide because it is a high quality, multi-center, prospective, randomized, controlled trial with a large number of patients, which gives us highly credible results. The study provides us with statistically sound evidence for simplifying our PD treatment practices-without sacrificing patient outcomes. The findings, which challenge existing treatment recommendations for peritoneal dialysis, should make it significantly easier for physicians to prescribe peritoneal dialysis and may also make it possible for many more patients to benefit from the therapy."

Declining kidney function results in higher levels of toxins and waste products in the blood. When the kidneys no longer adequately eliminate toxins from the bloodstream, peritoneal dialysis helps to clear these unwanted substances through the peritoneal membrane, commonly measured in terms of small solute clearances like urea and creatinine. This membrane, located in the abdominal region, serves as the therapy's natural waste filter and
'"/>

Contact: Stephanie Lazor
stephanie.lazor@mslpr.com
212-213-7265
Manning Selvage & Lee
28-Jun-2001


Page: 1 2 3 4 5

Related medicine news :

1. Landmark survey reveals asthma in children remains significantly out of control in the United States
2. Landmark antidepressant analysis demonstrated significant efficacy of Effexor®/Effexor XR
3. Landmark study shows coenzyme Q10 slows progressive decline in Parkinsons disease
4. Landmark XENDOS study shows Xenical prevents or delays the development of type 2 diabetes
5. Landmark study demonstrates potential for nerve regeneration treatment of stroke
6. Landmark study results published in NEJM highlight breakthrough treatment for heart failure
7. Landmark study uncovers reasons behind recurring back injury
8. Landmark clinical trial at 22 medical centers finds implanted heart pumps lengthen and improve lives of terminally ill heart failure patients
9. Landmark school-based social influences smoking-prevention program found not to work
10. U.S., British scientific societies honor penicillin as International Chemical Landmark
11. CODE-2*: Landmark study on the costs of type 2 diabetes in Europe

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/16/2019)... ... March 16, 2019 , ... Blood Flow ... Ligament (ACL) reconstruction patients often face bone and muscle loss immediately following the ... note that combining blood flow restriction (BFR) therapy with traditional rehabilitation efforts may ...
(Date:3/15/2019)... ... March 15, 2019 , ... ... announced the launch of its newly designed healthcare website, SMG3RX.com. Integrating a vibrant ... easily find a solution that fits their needs. , “We are thrilled to ...
(Date:3/15/2019)... ... March 15, 2019 , ... Esteemed Marietta dentist Dr. Michael ... Dental Assisting . The private dental assistant school is recognized as one of the ... a position within sixty days of graduation. Assisting 101 - School of Dental Assisting ...
(Date:3/15/2019)... ... 15, 2019 , ... The National Association of Chain Drug ... seven-day supply the initial prescriptions of opioids for acute pain – a move ... for prescribing opioids. , U.S. Sen. Kirsten Gillibrand (D-NY) and U.S. Sen. Cory ...
(Date:3/14/2019)... ... March 14, 2019 , ... When:    Wednesday, ... at Midtown - 1900 Long Beach Blvd., Long Beach, CA 90806 , What:    Los ... Housing, county and city officials, and other partners to celebrate the start of ...
Breaking Medicine News(10 mins):
(Date:3/14/2019)... ... 2019 , ... AxioMed announced today the issuance ... approval was received as a result of an accredited Notified Body assessment of ... clinical data regarding the viscoelastic AxioMed technology. , AxioMed first received CE ...
(Date:3/13/2019)... ... March 13, 2019 , ... Guard RFID Solutions Inc., a ... Tag (PT-3), a small and lightweight wearable RFID tag with a user-activated push ... in hazardous industrial environments. , “We have developed our most versatile tag to ...
(Date:3/13/2019)... ... March 13, 2019 , ... ... FocusOne Solutions ® has been recognized for its longevity as one of the ... has earned the Sustained Excellence Award which recognizes employers that have been ...
Breaking Medicine Technology:
Cached News: